Johnson & Johnson Company Culture

Mr. Alex Gorsky has been the Chairman and Chief Executive Officer of Johnson & Johnson since December 28, 2012 and April 26, 2012 respectively. Mr. Gorsky served as the Chief Operating Officer and Head of General Medicines at Novartis Pharmaceuticals Corporation from May 2004 to February 2008. He also served as the Chief Executive Officer of Novartis Pharmaceuticals from 2005 to February 2008 and as its Head of Pharma North America since 2005. He was responsible for North American pharmaceutical operations of NPC which includes both the United States and Canada. He served as Chief Executive of U.S at Novartis Corporation until February 2008. He served as Head of USA Pharmaceutical Business at Novartis AG until April 2008. He served as Worldwide Chairman of Surgical Care Group at Johnson & Johnson since January 1, 2009 until September 2009. He served for 15 years in various sales, marketing and management roles with Janssen Pharmaceutica, a Johnson & Johnson unit. He first joined Johnson & Johnson in 1988. In 2001, he was appointed President of Janssen's U.S. operations/president of Janssen Pharmaceutical Inc. As leader of Janssen's management board, Mr. Gorsky had responsibility for all of its functional areas, including: administration and community affairs; finance; human resources; information management; marketing; medical affairs; public relations; sales and process excellence. He began his pharmaceutical career as a sales representative and held various roles of increasing responsibility in sales, marketing and general management. He also oversaw the launches of Aciphex(R), a proton pump inhibitor for GI disorders and Reminyl(R), a treatment for Alzheimer's disease. Mr. Gorsky left Johnson & Johnson in 2004 to join the Novartis Pharmaceuticals Corporation. He served as Worldwide Chairman of the Surgical Care Group at Johnson & Johnson since 2009 and Worldwide Chairman of the Medical Devices and Diagnostics Group since September 2009. He served as Company Group Chairman of Johnson & Johnson's pharmaceutical business in Europe, the Middle East and Africa since 2003. He served for six years in the U.S. Army, finishing his career with the rank of Captain. During that same time, he earned the Ranger Tab, Airborne Wings and served in Europe, the United States and Panama. His landmark achievements at Janssen include the commercialization of blockbusters Risperdal(R), an atypical anti-psychotic medicine and Duragesic(R) for pain. Mr. Gorsky served as Company Group Chairman of for Ethicon Inc. since 2008. Mr. Gorsky has been a Director of Johnson & Johnson since April 26, 2012. He has been a Director at International Business Machines Corporation since September 1, 2014. He serves on the board of AdvaMed, the U.S. trade association for the medical device and diagnostics industry. He is an Executive Sponsor of two Johnson & Johnson affinity groups, the Women's Leadership Initiative and the Veteran's Leadership Council. He is actively involved in the National Alliance for the Mentally Ill, the National Alliance on Aging, the Philadelphia College of Pharmacy, the Doylestown Hospital Board, the Boy Scouts of America and as a Youth League Coach for Lacrosse. Mr. Gorsky also serves on the boards of the Travis Manion Foundation, the Congressional Medal of Honor Foundation, the National Academy Foundation and the Wharton Board of Overseers. He is a member of the Business Roundtable and The Business Council. A longtime advocate of diversity and inclusion, Mr. Gorsky was named the 2009 Mentor of the Year by the Healthcare Businesswomen's Association. Mr. Gorsky holds a Bachelor's of science degree from the U.S. Military Academy in West Point, N.Y., in 1982. He obtained a Master of Business Administration degree from The Wharton School of the University of Pennsylvania in 1996.

Mr. Joaquin Duato has been Worldwide Chairman of Pharmaceuticals at Johnson & Johnson since January 3, 2011 and has been its Executive Vice President since April 9, 2016. Mr. Duato served as Group Chairman of Johnson & Johnson until January 3, 2011. He has been a Trustee of Save The Children Federation, Incorporated since 2012. He is responsible for the global commercial businesses of the Janssen Pharmaceutical Companies of Johnson & Johnson. Mr. Duato oversees the Operations, Quality and Compliance functional groups that support the pharmaceutical Commercial and Research & Development organizations. Previously, he was Company Group Chairman, Ortho Clinical Diagnostics, Inc., once a Johnson & Johnson company in the Medical Devices & Diagnostics segment. Joaquin's professional experience in the healthcare industry spans sales, marketing and general management. He began his career at Johnson & Johnson in 1989 with Janssen-Cilag Spain and later became Managing Director of Janssen-Cilag Italy. He then led Ortho Biotech Europe before relocating to the United States in 2002 to serve as President, Ortho Biotech Products, L.P. in 2005. A native of Valencia, Spain, Joaquin holds an undergraduate degree in economics and two master's degrees ??? one in business administration from ESADE Business School in Barcelona; the other in international management from Thunderbird in Phoenix, Arizona. Joaquin is a member of the Board of Directors of the Pharmaceutical Research & Manufacturers of America (PhRMA). He currently serves as its elected Treasurer and chair of the State Committee. He is also a member of the Board of the European Federation of the Pharmaceutical Industry and Associations (EFPIA), the Board of Trustees of Save the Children and the International Advisory Board of the ESADE Business School.

Ms. Sandra E. Peterson, also known as Sandi, has been Group Worldwide Chairman at Johnson & Johnson since December 1, 2012 and served as its Executive Vice President since May 2, 2016 until August 8, 2017. Ms. Peterson served as the President of Diabetes Care Division at Bayer HealthCare AG from May 10, 2005 to 2009. She has over a decade of experience on the board of another U.S. public company, Dun & Bradstreet. She served as the President of Diabetes Care Division at Bayer Healthcare LLC. She served as the Chairwoman of Management Board and Chief Executive Officer at Bayer CropScience AG, a division of Bayer AG from October 1, 2010 to November 30, 2012 and served as its Member of Board of Management from July 1, 2010 to November 30, 2012. She served as the Head of The Medical Care Division - Bayer HealthCare at Bayer AG from January 2009 to October 1, 2010. She served as the Head of Medical Care Division - Bayer HealthCare at Bayer CropScience AG from January 2009 to October 1, 2010. She served as a Senior Vice President of Health usinesses at Medco Health Solutions, Inc. from December 1998 to August 2003 and served as its Group President of Government - Medco Health from September 2003 to February 2004. She served as Senior Vice President of Marketing at Merck-Medco Managed Care LLC from January 1999 to March 2001. Her areas of responsibility at Medco included business development, strategy, cooperation management, product development, branding and marketing. As an Executive Management team member, she played a role in the strategic spin-off of Medco Health from Merck & Co., Inc. She served as Group President of Medco Health Solutions, Inc. She served as an Executive Vice President of Research & Development at RJR Nabisco Holdings Group, Inc., from April 8, 1996 to December 31, 1998. She held various executive positions at Nabisco and Whirlpool Corporation. She served as Management Consultant of McKinsey & Company from 1987 to 1993 and worked on brand marketing strategies, innovative product development and new business. From 1993 to 1996, she held various global executive positions with home appliances manufacturer Whirlpool Corporation. She serves as the Chairman of the Board at Wildlife Trust. Ms. Peterson has been an Independent Director of Microsoft Corporation since December 2, 2015. She served as a Director of Dun & Bradstreet, Inc./Dun & Bradstreet Corp. from September 2002 to October 2015. She served as a Director of Handleman Company from 2001 to November 16, 2005. She received a fellowship from the Robert Bosch Foundation in Stuttgart, Germany and spent a year serving with the German Finance Ministry and the Federation of German Industries. Ms. Peterson holds a B.A. in Government from Cornell University and an M.P.A. degree in Applied Economics from Princeton University.

Mr. William D. Perez, also known as Bill, has been a Senior Advisor of Greenhill & Co., Inc. since January 2010. Mr. Perez served as the President and Chief Executive Officer of Wm. Wrigley Jr. Company. from October 23, 2006 to December 31, 2008 and served as its Member of Executive Leadership Team. He also served as an Advisor of Wm. Wrigley Jr. Company from October 2008 to December 31, 2008. He served as the Chief Executive Officer and President of The Wrigley Co. Ltd. He served as the President and Chief Executive Officer of Nike Inc. from December 28, 2004 to January 2006. Mr. Perez spent 34 years with S. C. Johnson & Son, Inc., including eight years at the multi-billion dollar privately held global consumer products company based in Racine, Wisconsin. He served as President of S. C. Johnson & Son, Inc. from 1993 to November 2004, Chief Operating Officer from 1993 to November 2004 and Chief Executive Officer from 1996 to November 2004. His career began in 1970 as a sales representative in Cleveland, Ohio, for S. C. Johnson & Son, Inc., one of the world's leading manufacturers of household consumer products which markets and distributes its well-known brands such as Edge(R), Glade(R), Windex(R) and Ziploc(R) in more than 110 countries. He served as General Manager of both S.C. Johnson Spain and Iberia, Vice President and Regional Director of Consumer Products in Latin America, Vice President of the U.S. Home Care business and Executive Vice President of Consumer Products for North America. He is a Co-founder of The Wrigley Co. Ltd. and served as its Executive Chairman. Mr. Perez has been an Independent Director at Johnson & Johnson since June 12, 2007. He has been an Independent Director of Whirlpool Corporation since December 2009. He serves as a Trustee of Cornell University, Northwestern Memorial Hospital and the Chicago Boys and Girls Club. He serves as a Director of Grocery Manufacturers of America. He served as a Director of Wm. Wrigley Jr. Company from October 23, 2006 to October 2008; Campbell Soup Co. from June 1, 2009 to November 14, 2012; Hallmark Cards, Inc.; May Department Stores Co. from 1998 to May 21, 2004; Kellogg Company from 2000 to November 14, 2006 and Nike Inc. from December 28, 2004 to January 2006. He served as a Director of Grocery Manufacturers Association. He is a member of the Cornell University Council. Mr. Perez received his Bachelor of Arts degree in Government from Cornell University and a graduate degree in International Management from the Thunderbird School of Global Management.

Dr. Paulus A. Stoffels Ph.D., M.D., also known as Paul, has been Chief Scientific Officer and Executive Vice President at Johnson & Johnson since October 1, 2012 and May 2, 2016 respectively and served as its Worldwide Chairman of Pharmaceuticals until May 2, 2016. Dr. Stoffels serves as the Global Head at Johnson & Johnson Pharmaceutical Research & Development. He serves as a Member of Scientific Advisory Board of Index Life VI. Dr. Stoffels co-founded Tibotec-Virco NV in 2001 and served as its Chairman and Managing Director. Dr. Stoffels served as the Cha irman of Tibotec BVBA, a subsidiary of Johnson & Johnson. He served as a Director of Galapagos NV (Galapagos Genomics NV). He is the Worldwide Chairman of Pharmaceuticals of Janssen Research & Development, LLC. He holds a Medical degree from the University of Antwerp and training in infectious diseases from the Institute of Tropical Medicine in Antwerp. Dr. Stoffels studied medicine at the University of Diepenbeek and the University of Antwerp, Belgium and infectious diseases and tropical medicine at the Institute of Tropical Medicine, also in Antwerp.

Ms. Ashley A. McEvoy has been Company Group Chairman of Consumer Medical Devices at Johnson & Johnson since March 14, 2017. Ms. McEvoy served as Group Chairman of Johnson and Johnson Vision Care at Johnson & Johnson until March 14, 2017. She served as President of McNeil Consumer & Specialty Pharmaceuticals since 2006. Ms. McEvoy has worldwide responsibility for the strategic direction of McNeil Consumer & Specialty Healthcare's upper respiratory, pain and gastrointestinal franchises and she heads the over-the-counter (OTC) business in the U.S. She joined McNeil in 1996 as an Assistant Brand Manager for Tylenol and Nicotrol. Within two years, she was managing Tylenol's marketing and public relations. By 2003, as Vice President of Marketing, she drove the OTC business for McNeil Consumer & Specialty Pharmaceuticals. She served as General Manager of McNeil Consumer Healthcare, a division of McNeil Consumer & Specialty Pharmaceuticals since 2005. She served as WW President of Ethicon Products at Johnson & Johnson from January 2009 to December 2011. She serves as Vice Chairman and Director at Consumer Healthcare Products Association. She studied Bachelor of Arts in Communications and Business from University of Pennsylvania from 1988 to 1992.

Mr. Jorge S. Mesquita has been Worldwide Chairman of Consumer Companies at Johnson & Johnson since December 15, 2014 and has been its Executive Vice President since April 9, 2016. Mr. Mesquita served as the Group President of New Business Creation & Innovation for Global Snacks & Pet Care at The Procter & Gamble Company. He served as Group President ' New Business Creation and Innovation of The Procter & Gamble Company, from March 14, 2012 to June 2013 and served as Group President - Special Assignment from January 1, 2012 to March 13, 2012. Prior to that, he served as President of Commercial Products and President of P&G Professional from 2006 to 2007. He served as Group President of Global Fabric Care from 2007 to 2011 and The Procter & Gamble Company since 2006 and also served as its President of Global Home Care since 2001 to 2007. He led the Global Fabric Care from 2007 to 2012 and Global Home Care from 2001 to 2007. He served in Different position at Procter & Gamble which include: Mr. Mesquita served as Product Development, Venezuela since 1984; Assistant Brand Manager, Crest-Venezuela since 1987; Brand Manager, Camay and Crest-Venezuela since 1988; Marketing Manager, Beauty Care-Venezuela since 1989; Marketing Manager, Hair Care, Dishwashing, Softeners and Household Cleaners-Mexico since 1990; Marketing Director, Beauty Care Products-Mexico since 1992; Marketing Director-Brazil since 1993; General Manager, Paper Products-Mexico since 1995; General Manager, Laundry and Cleaning Products-Mexico since 1997; Vice President and General Manager, Laundry, Cleaning and Toilet Tissue Products-Mexico, Procter & Gamble Latin America since 1998; Vice President-Latin America Fabric & Home Care and Vice President-North America Fabric Care since 1999. He has been Director of Cadbury Nigeria Plc since May 2012. He has been an Independent Director of Mondelez International, Inc. since May 23, 2012. He served as a Director at The American Cleaning Institute. He served on the board of trustees of the Cincinnati Opera Association. Mr. Mesquita educated at Florida Institute of Technology, B.S., Chemical Engineering, 1983.

Dr. Guy J. Lebeau, M.D., serves as Group Chairman of MD&D Business - EMEA at Johnson & Johnson. Dr. Lebeau serves as Chairman and Director of European Medical Technology Industry Association.